positions available now

Monthly Archives: July 2015

Commercial Eyes has a Victorian Poisons and Controlled Substances Licence

Commercial Eyes has been issued with a Victorian Poisons and Controlled Substances Licence. This licence allows Commercial Eyes to handle Schedule 2 (Pharmacy Medicines), Schedule 3 (Pharmacist Only Medicines (excluding pseudoephedrine)) and Schedule 4 (Prescription Only Medicines (excluding drugs of … Continue reading

Posted in Commercial Eyes, Life Sciences Industry, Medical Services, Regulatory Services | Comments Off on Commercial Eyes has a Victorian Poisons and Controlled Substances Licence

Independent Review of Medicines and Medical Devices Regulation

This week, Pharma in Focus interviewed one of our Senior Regulatory consultants, Dr Greg Pearce, for his commentary on the stage 1 report from the independent review of Medicines and Medical Devices regulation. Released last month, the report is currently … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged | Comments Off on Independent Review of Medicines and Medical Devices Regulation

From the frontline of the Nepal earthquake

At our July Conference each year, we relish the opportunity to hear from one of the charities we have supported over the previous 12 months. This year, we were grateful to hear from Margaret Bell, Women’s Health Advisor and Medical … Continue reading

Posted in Commercial Eyes | Tagged | Comments Off on From the frontline of the Nepal earthquake

CEPL welcomes Pharmacy Guild, GMIA and GSK to staff development day

This week, our staff has come together for our annual July Conference. This is a valuable staff development event well established in the Commercial Eyes calendar. This year we welcomed guest speakers Angelo Pricolo, Pharmacist and Pharmacy Guild Committee Member, … Continue reading

Posted in Commercial Eyes, Life Sciences Industry | Comments Off on CEPL welcomes Pharmacy Guild, GMIA and GSK to staff development day

In a world of rapidly evolving technology, can we maintain regulatory clarity?

This was the question asked at a recent roundtable discussion hosted by BioMelbourne Network. Invited by the TGA, industry representatives were brought together to assess the new Software as a Medical Device (SaMD) guidance on the application of appropriate quality … Continue reading

Posted in BioMelbourne Network, Regulatory Services, TGA | Tagged | Comments Off on In a world of rapidly evolving technology, can we maintain regulatory clarity?

FDA tick of approval: Commercial Eyes’ Drug Safety Group has been successfully audited by the FDA!

Commercial Eyes has been successfully audited by the US Food and Drug Administration (FDA) and found to have no written 483 observations. This is an excellent result that confirms Commercial Eyes’ reputation as the foremost pharmacovigilance and medical information provider … Continue reading

Posted in Commercial Eyes, FDA, Life Sciences Industry, Medical Services | Comments Off on FDA tick of approval: Commercial Eyes’ Drug Safety Group has been successfully audited by the FDA!

Andrew Carter – New Chair of BioMelbourne Network

The BioMelbourne Network has announced that our Managing Director, Andrew Carter, has been elected by the Board to succeed Andrew Macdonald as Chair, effective from the 1st of July, 2015. Andrew Carter was appointed as a Director in 2014 and … Continue reading

Posted in BioMelbourne Network, Commercial Eyes, Life Sciences Industry | Comments Off on Andrew Carter – New Chair of BioMelbourne Network
Copyright © 2014 Commercial Eyes